GoodRx Holdings (GDRX) Interest Expenses (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Interest Expenses data on file, last reported at $9.8 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 8.24% year-over-year to $9.8 million; the trailing twelve-month figure through Mar 2026 stood at $42.2 million (down 13.8% YoY), and the FY2025 full-year result was $42.6 million, down 22.68% from the prior year.
• Interest Expenses fell to $9.8 million in Q1 2026, from $10.4 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $165.3 million in Q1 2022 to a low of -$15.9 million in Q4 2022.
• A 5-year average of $19.8 million and a median of $13.1 million in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 98.43% in 2022 and soared 193.12% in 2023, its largest moves.
• Tracing GDRX's Interest Expenses over 5 years: stood at -$15.9 million in 2022, then soared by 193.12% to $14.8 million in 2023, then dropped by 23.37% to $11.4 million in 2024, then declined by 8.41% to $10.4 million in 2025, then dropped by 6.11% to $9.8 million in 2026.
• Business Quant data shows GDRX's Interest Expenses at $9.8 million in Q1 2026, $10.4 million in Q4 2025, and $14.7 million in Q3 2025.